1. Home
  2. MRNA vs PRMB Comparison

MRNA vs PRMB Comparison

Compare MRNA & PRMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • PRMB
  • Stock Information
  • Founded
  • MRNA 2010
  • PRMB 1955
  • Country
  • MRNA United States
  • PRMB United States
  • Employees
  • MRNA N/A
  • PRMB N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • PRMB
  • Sector
  • MRNA Health Care
  • PRMB
  • Exchange
  • MRNA Nasdaq
  • PRMB Nasdaq
  • Market Cap
  • MRNA 9.8B
  • PRMB 8.4B
  • IPO Year
  • MRNA 2018
  • PRMB N/A
  • Fundamental
  • Price
  • MRNA $25.18
  • PRMB $22.03
  • Analyst Decision
  • MRNA Hold
  • PRMB Buy
  • Analyst Count
  • MRNA 15
  • PRMB 12
  • Target Price
  • MRNA $37.15
  • PRMB $35.33
  • AVG Volume (30 Days)
  • MRNA 10.8M
  • PRMB 3.3M
  • Earning Date
  • MRNA 11-06-2025
  • PRMB 11-06-2025
  • Dividend Yield
  • MRNA N/A
  • PRMB 1.82%
  • EPS Growth
  • MRNA N/A
  • PRMB N/A
  • EPS
  • MRNA N/A
  • PRMB N/A
  • Revenue
  • MRNA $3,078,000,000.00
  • PRMB $6,046,100,000.00
  • Revenue This Year
  • MRNA N/A
  • PRMB $33.47
  • Revenue Next Year
  • MRNA $11.12
  • PRMB $4.01
  • P/E Ratio
  • MRNA N/A
  • PRMB N/A
  • Revenue Growth
  • MRNA N/A
  • PRMB 26.25
  • 52 Week Low
  • MRNA $23.15
  • PRMB $21.37
  • 52 Week High
  • MRNA $56.70
  • PRMB $35.85
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 44.51
  • PRMB 44.10
  • Support Level
  • MRNA $24.25
  • PRMB $21.42
  • Resistance Level
  • MRNA $29.20
  • PRMB $22.12
  • Average True Range (ATR)
  • MRNA 1.50
  • PRMB 0.52
  • MACD
  • MRNA -0.13
  • PRMB 0.04
  • Stochastic Oscillator
  • MRNA 16.97
  • PRMB 42.13

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About PRMB Primo Brands Corporation Class A Common Stock

Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.

Share on Social Networks: